JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2021, Vol. 23 ›› Issue (3): 395-399.DOI: 10.3969/j.issn.1671-2587.2021.03.023
Previous Articles Next Articles
Received:
2021-03-11
Online:
2021-06-20
Published:
2021-06-22
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.lcsxyjy.com/EN/10.3969/j.issn.1671-2587.2021.03.023
[1] TROÌA L,AL-KOUATLY H B,MCCURDY R,et al.The recurrence risk of fetomaternal hemorrhage[J].Fetal Diagn Ther,2019,45(1):1-12. [2] LEE A I,KAUFMAN R M.Transfusion medicine and the pregnant patient[J].Hematol Oncol Clin North Am,2011,25(2):393-413,ix. [3] KIM Y A,MAKAR R S.Detection of fetomaternal hemorrhage[J].Am J Hematol,2012,87(4):417-423. [4] LARSEN R,BERKOWICZ A,LOUSEN T,et al.Massive fetomaternal hemorrhage:clearance of fetal red blood cells after intravenous anti-D prophylaxis monitored by flow cytometry[J].Transfusion,2008,48(8):1707-1712. [5] PORRA V,BERNAUD J,GUERET P,et al.Identification and quantification of fetal red blood cells in maternal blood by a dual-color flow cytometric method:evaluation of the Fetal Cell Count kit[J].Transfusion,2007,47(7):1281-1289. [6] BOWMAN J M,POLLOCK J M,PENSTON L E.Fetomaternal transplacental hemorrhage during pregnancy and after delivery[J].Vox Sang,1986,51(2):117-121. [7] STROUSTRUP A,PLAFKIN C,SAVITZ D A.Impact of physician awareness on diagnosis of fetomaternal hemorrhage[J].Neonatology,2014,105(4):250-255. [8] KECSKES Z.Large fetomaternal hemorrhage:clinical presentation and outcome[J].J Matern Fetal Neonatal Med,2003,13(2):128-132. [9] KOELEWIJN J M,DE HAAS M,VRIJKOTTE T G,et al.Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis[J].BJOG,2009,116(10):1307-1314. [10] ZIPURSKY A,HULL A,WHITE F D,et al.Foetal erythrocytes in the maternal circulation[J].Lancet,1959,1(7070):451-452. [11] ]MUENCH MV, BASCHAT AA, REDDY UM, et al.Kleihauer-betke testing is important in all cases of maternal trauma[J].J Trauma.2004,57(5):1094-1098. [12] KRYWKO DM, YARRARAPU SNS, SHUNKWILER SM.Kleihauer Betke Test[J/OL].StatPearls[Internet].2021.https://www.ncbi.nlm.nih.gov/books/NBK430876/. [13] WYLIE B J,D'ALTON M E.Fetomaternal hemorrhage[J].Obstet Gynecol,2010,115(5):1039-1051. [14] ZHANG Z R,GE J,GONG Z,et al.Evaluation of machine learning-driven automated Kleihauer-Betke counting:a method comparison study[J].Int J Lab Hematol,2020.DOI:10.1111/ijlh.13380. [15] KUMPEL B M,MACDONALD A P,BISHOP D R,et al.Quantitation of fetomaternal haemorrhage and F cells in unusual maternal blood samples by flow cytometry using anti-D and anti-HbF[J].Transfus Med,2013,23(3):175-186. [16] BROMILOW I M,DUGUID J K.Measurement of feto-maternal haemorrhage:a comparative study of three Kleihauer techniques and tow flow cytometry methods[J].Clin Lab Haematol,1997,19(2):137-142. [17] PELIKAN D M,SCHERJON S A,MESKER W E,et al.Quantification of fetomaternal hemorrhage:a comparative study of the manual and automated microscopic Kleihauer-Betke tests and flow cytometry in clinical samples[J].Am J Obstet Gynecol,2004,191(2):551-557. [18] CHEN J C,DAVIS B H,WOOD B,et al.Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detection[J].Cytometry,2002,50(6):285-290. [19] KENNEDY G A,SHAW R,JUST S,et al.Quantification of feto-maternal haemorrhage (FMH) by flow cytometry:anti-fetal haemoglobin labelling potentially underestimates massive FMH in comparison to labelling with anti-D[J].Transfus Med,2003,13(1):25-33. [20] STEFANOVIC V.Fetomaternal hemorrhage complicated pregnancy:risks,identification,and management[J].Curr Opin Obstet Gynecol,2016,28(2):86-94. [21] COSMI E,MARI G,DELLE CHIAIE L,et al.Noninvasi ve diagnosis by Doppler ultrasonography of fetal Anemia resulting from parvovirus infection[J].Am J Obstet Gynecol,2002,187(5):1290-1293. [22] HERMANN M,POISSONNIER M H,GRANGÉ G.Cerebral Doppler velocimetry to predict fetal Anemia after more than three intravenous fetal exchange transfusions[J].Transfusion,2014,54(11):2968-2973. [23] BATAILLE P,PETIT L,WINER N.Performance of the Kleihauer Betke test in the prediction of neonatal Anemia[J].J Matern Fetal Neonatal Med,2020:1-7. [24] MARI G,DETER R L,CARPENTER R L,et al.Noninvasive diagnosis by Doppler ultrasonography of fetal Anemia due to maternal red-cell alloimmunization.Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses[J].N Engl J Med,2000,342(1):9-14. [25] BELLUSSI F,PEROLO A,GHI T,et al.Diagnosis of severe fetomaternal hemorrhage with fetal cerebral Doppler:case series and systematic review[J].Fetal Diagn Ther,2017,41(1):1-7. [26] 李玮璟,李瑞满,石晓蓝,等.多普勒超声技术用于诊治5例母胎间输血所致胎儿贫血[J].中国实用妇科与产科杂志,2006,22(11):859-861. [27] BENEVENTI F,CAVAGNOLI C,LOCATELLI E,et al.Mild-to-moderate foeto-maternal haemorrhage in the third trimester and at term of pregnancy:quantitative determination and clinical-diagnostic evaluation[J].Blood Transfus,2018,16(3):302-306. [28] UMAZUME T,MORIKAWA M,YAMADA T,et al.Long-term persistent fetomaternal hemorrhage[J].Clin Case Rep,2015,3(11):916-919. [29] PIVA I,IANNONE P,MORANO D,et al.Untimely diagnosis of fetomaternal hemorrhage:what went wrong?[J].J Perinat Med,2018,47(1):61-67. [30] MARK K.FUNG.AABB技术手册[M].18版.长沙:中南大学出版社,2019. [31] 程伟,富宁.人胎儿血红蛋白的检测及其临床意义[J].中国实验诊断学,2009,13(10):1474-1476. [32] HIDA S.Measurement of alpha-fetoprotein and fetal erythrocyte levels for detecting fetomaternal hemorrhage[J].Asia Oceania J Obstet Gynaecol,1989,15(1):41-45. [33] BANERJEE K,KRIPLANI A,KUMAR V,et al.Detecti ng fetomaternal hemorrhage after first-trimester abortion with the Kleihauer-Betke test and rise in maternal serum alpha-fetoprotein[J].J Reprod Med,2004,49(3):205-209. [34] 刘莹.母血中HbF及AFP预测FMH的临床应用价值[J].中国现代药物应用,2017,11(11):83-84. [35] DEN BESTEN G,VAN DER WEIDE K,SCHUERMAN F A B A,et al.Establishing the cause of Anemia in a premature newborn infant[J].Lab Med,2018,49(3):e74-e77. [36] 刘丽娜,尹文,胡兴斌.毛细管超速离心法在输血后患者Rh血型鉴定中的应用分析[J].临床输血与检验,2018,20(6):643-646. [37] WESTHOFF C M.Blood group genotyping[J].Blood,2019,133(17):1814-1820. [38] LUBUSKY M,SIMETKA O,STUDNICKOVA M,et al.Fetomaternal hemorrhage in normal vaginal delivery and in delivery by cesarean section[J].Transfusion,2012,52(9):1977-1982. [39] VOTINO C,MIRLESSE V,GOURAND L,et al.Successful treatment of a severe second trimester fetomaternal hemorrhage by repeated fetal intravascular transfusions[J].Fetal Diagn Ther,2008,24(4):503-505. [40] MARI G,ZIMMERMANN R,MOISE K J JR,et al.Correlation between middle cerebral artery peak systolic velocity and fetal hemoglobin after 2 previous intrauterine transfusions[J].Am J Obstet Gynecol,2005,193(3 Pt 2):1117-1120. [41] DEKA D,DADHWAL V,SHARMA A K,et al.Perinatal survival and procedure-related complications after intrauterine transfusion for red cell alloimmunization[J].Arch Gynecol Obstet,2016,293(5):967-973. [42] WILLIAMS J E,PUGH Y.The late preterm:a population at risk[J].Crit Care Nurs Clin N Am,2018,30(4):431-443. [43] LINDENBURG I T,VAN KAMP I L,OEPKES D.Intrauterine blood transfusion:current indications and associated risks[J].Fetal Diagn Ther,2014,36(4):263-271. [44] MELETI D,DE OLIVEIRA L G,ARAUJO JÚNIOR E,et al.Evaluation of passage of fetal erythrocytes into maternal circulation after invasive obstetric procedures[J].J Obstet Gynaecol Res,2013,39(9):1374-1382. [45] NOMURA R M,FERREIRA M V,LATIF I O,et al.Agreement between maternal perception of fetal movements and visualization by ultrasound[J].Rev Bras Ginecol Obstet,2013,35(2):55-59. [46] DODD J M,WINDRIM R C,VAN KAMP I L.Techniques of intrauterine fetal transfusion for women with red-cell isoimmunisation for improving health outcomes[J].Cochrane Database Syst Rev,2012(9):CD007096. [47] 李杨,何燕京,白英哲,等.胎母输血综合症影响产妇ABO血型鉴定1例[J].中国输血杂志,2018,31(5):549-551. |
[1] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(3): 273-293. |
[2] | ZHANG Yuan-qin, WANG Mei-ru, XU Lu, et al. Study of Capillary Ultracentrifugation Technique on Prediction of Massive Maternal Transfusion Syndrome in Vitro [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(3): 301-305. |
[3] | QUAN Jun-hui, ZHANG Ming-gang, SHAO Xiang, et al. Rh Phenotype Distribution and Red Blood Cells Antigen Matching for Transfusion in Blood Donors and Recipients in Xi'an [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(3): 310-314. |
[4] | QIN Yu-si, LI Yuan-bo, XUE Ying-hong, et al. Analysis of the Application of Autotransfusion in the Operation of Gynecological Tumor Patients [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(3): 314-318. |
[5] | YANG Gong-xun, GAO Ran, YANG Zheng. Thromboelastography-guided Therapy Improves Patient Blood Management during Surgical Operation: A Systematic Review and Analysis [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(3): 319-323. |
[6] | YAN Ye, ZHANG Qin, WANG Li-na, et al. Combined Application of Screening Cells with Two Different Antigen Patterns [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(3): 324-327. |
[7] | CHEN Lan-lan, ZHANG Yan-hua, CHE Jin, et al. Analysis on Blood Routine Indicators and Others in Frequent Platelet Apheresis Donors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(3): 332-336. |
[8] | LIU Ai-ping, WANG Li-cun, SHAO Chang-feng, et al. Research on the Educational Mode of Clinical Blood Transfusion Based on Occupational Competency [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(3): 380-384. |
[9] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(3): 391-394. |
[10] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(3): 404-408. |
[11] | JIA Yan-jun, ZHAO Xu-ying, WEI Zhen-zhen. Effects of Resveratrol on Platelet Oxidative Stress and Aging Index and Storage Time [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 137-141. |
[12] | WANG Hui-ru, LIU Hui-lan. Factors Influencing Blood Transfusion in Patients after Unrelated Umbilical Cord Blood Transplantation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 162-166. |
[13] | ZHANG Yuan-yuan, YING Mei-ai, PAN Jian, et al. The Clinical Effect of Plasma Exchange in ABO Incompatible Relatives in vivo Kidney Transplantation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 167-172. |
[14] | WANG Lei, WU Xue-zhong. Retrospective Analysis of Rh (D,C, c, E, e) Antigens Compatibility between Blood Recipients and Donors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 181-185. |
[15] | GAN Shan, DUAN Ling, HU Hong-bing. The Clinical Use of Blood in Exchange Transfusion for Severe Neonatal Hyperbilirubinemia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 185-188. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||